These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8584586)

  • 61. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Psychosocial family intervention in schizophrenia: a review of empirical studies.
    Lam DH
    Psychol Med; 1991 May; 21(2):423-41. PubMed ID: 1876647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.
    Kamali M; Kelly L; Gervin M; Browne S; Larkin C; O'Callaghan E
    Psychiatr Serv; 2001 Feb; 52(2):161-3, 166. PubMed ID: 11157110
    [No Abstract]   [Full Text] [Related]  

  • 64. Maintenance medication for schizophrenia: strategies for dose reduction.
    Schooler NR
    Schizophr Bull; 1991; 17(2):311-24. PubMed ID: 1679254
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relapse and rehospitalization: comparing oral and depot antipsychotics.
    Schooler NR
    J Clin Psychiatry; 2003; 64 Suppl 16():14-7. PubMed ID: 14680414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment, expressed emotion and relapse in recent onset schizophrenic disorders.
    Linszen D; Dingemans P; Van der Does JW; Nugter A; Scholte P; Lenior R; Goldstein MJ
    Psychol Med; 1996 Mar; 26(2):333-42. PubMed ID: 8685289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. "Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial.
    Remington G; Seeman P; Feingold A; Mann S; Shammi C; Kapur S
    J Clin Psychiatry; 2011 Aug; 72(8):1042-8. PubMed ID: 20868639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of combined pharmaco- and psychotherapy in schizophrenia ambulatory care on rehospitalization incidents and treatment costs].
    Müller P; Schöneich D
    Psychiatr Prax; 1992 Jul; 19(4):91-5. PubMed ID: 1354881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Schizophrenia: a study comparing a family therapy group following a paradoxical model plus psychodrugs and a group treated by the conventional clinical approach.
    De Giacomo P; Pierri G; Santoni Rugiu A; Buonsante M; Vadruccio F; Zavoianni L
    Acta Psychiatr Scand; 1997 Mar; 95(3):183-8. PubMed ID: 9111850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Individual psychotherapy and persons with serious mental illness: the clients' perspective.
    Coursey RD; Keller AB; Farrell EW
    Schizophr Bull; 1995; 21(2):283-301. PubMed ID: 7631175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optimal treatment strategies to enhance recovery from schizophrenia.
    Falloon IR; Held T; Roncone R; Coverdale JH; Laidlaw TM
    Aust N Z J Psychiatry; 1998 Feb; 32(1):43-9. PubMed ID: 9565182
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The natural course of schizophrenia and effective maintenance drug treatment.
    Davis JM; Andriukaitis S
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Psychosocial treatments in schizophrenia: a review of the past 20 years.
    Huxley NA; Rendall M; Sederer L
    J Nerv Ment Dis; 2000 Apr; 188(4):187-201. PubMed ID: 10789995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].
    Bechdolf A; Laier S; Kallenbach M; Biester A; Leopold K
    Nervenarzt; 2015 Nov; 86(11):1424-6. PubMed ID: 26542156
    [No Abstract]   [Full Text] [Related]  

  • 78. [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro].
    Lambert M; Correll C
    Nervenarzt; 2015 Nov; 86(11):1420-3. PubMed ID: 26542155
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia.
    Klingberg S; Wittorf A; Fischer A; Jakob-Deters K; Buchkremer G; Wiedemann G
    Acta Psychiatr Scand; 2010 May; 121(5):340-50. PubMed ID: 19895624
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.
    Herz MI; Szymanski HV; Simon JC
    Am J Psychiatry; 1982 Jul; 139(7):918-22. PubMed ID: 6124133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.